Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
African Swine Fever Virus (ASFV) has spread worldwide, and the lack of vaccines severely negatively impacts the pig industry. In this study, the p14.5 protein encoded by ASFV was used as the antigen, and the p14.5 gene was expressed in vitro using the expression system. Three new functionally recombinant () were constructed and the expressions of the p14.5 protein, p14.5-IL-33-Mus fusion protein and CTA1-p14.5-D-D fusion protein were successfully detected using Western blot analysis. After oral immunization of SPF mice with recombinant , flow cytometry and ELISA were performed to detect the differentiation and maturity of T lymphocytes, B lymphocytes and DCs of the mice, which were higher than those of the control group. Specific antibodies were produced. The immunogenicity of the adjuvant group was stronger than that of the single antigen group, and the IL-33 adjuvant effect was stronger than that of the CTA1-DD adjuvant.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950097 | PMC |
| http://dx.doi.org/10.3390/vaccines10030355 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of Peptide-Based Vaccines Against in -Infected Mice.
Vaccines (Basel)
June 2025
School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Background: (GAS) is a major human pathogen associated with serious diseases. Evaluating immune responses against GAS vaccines-immunogenicity, quality, and efficacy-is complicated by interference from co-infections, like (). We aimed to evaluate peptide-based GAS vaccines in mice for antisera efficacy against standard and mutant GAS strains and to assess immunological methods under co-infection conditions.
View Article and Find Full Text PDFMutational analysis reveals a novel role for hepatitis C virus NS5A domain I in cyclophilin-dependent genome replication.
J Gen Virol
September 2023
School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
The hepatitis C virus (HCV) NS5A protein is comprised of three domains (D1-3). Previously, we observed that two alanine substitutions in D1 (V67A, P145A) abrogated replication of a genotype 2a isolate (JFH-1) sub-genomic replicon (SGR) in Huh7 cells, but this phenotype was partially restored in Huh7.5 cells.
View Article and Find Full Text PDFNS5A domain I antagonises PKR to facilitate the assembly of infectious hepatitis C virus particles.
PLoS Pathog
February 2023
School of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom.
Hepatitis C virus NS5A is a multifunctional phosphoprotein comprised of three domains (DI, DII and DIII). DI and DII have been shown to function in genome replication, whereas DIII has a role in virus assembly. We previously demonstrated that DI in genotype 2a (JFH1) also plays a role in virus assembly, exemplified by the P145A mutant which blocked infectious virus production.
View Article and Find Full Text PDFIntegrative View of the Diversity and Evolution of SWEET and SemiSWEET Sugar Transporters.
Front Plant Sci
December 2017
College of Plant Protection, Shenyang Agricultural University, Shenyang, China.
Sugars Will Eventually be Exported Transporter (SWEET) and SemiSWEET are recently characterized families of sugar transporters in eukaryotes and prokaryotes, respectively. SemiSWEETs contain 3 transmembrane helices (TMHs), while SWEETs contain 7. Here, we performed sequence-based comprehensive analyses for SWEETs and SemiSWEETs across the biosphere.
View Article and Find Full Text PDFEnhancing Vaccine Efficacy by Engineering a Complex Synthetic Peptide To Become a Super Immunogen.
J Immunol
October 2017
The QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia; and
Peptides offer enormous promise as vaccines to prevent and protect against many infectious and noninfectious diseases. However, to date, limited vaccine efficacy has been reported and none have been licensed for human use. Innovative ways to enhance their immunogenicity are being tested, but rational sequence modification as a means to improve immune responsiveness has been neglected.
View Article and Find Full Text PDF